James Cook University Subject Handbook - 2021

PC3303 - Integrated Therapeutics 3

Subject Description

Mental health, musculoskeletal and related pain conditions and respiratory conditions represent a significant health burden in Australia. This subject will explore the most significant psychological, respiratory and musculoskeletal conditions that affect the Australian population including a focus on differences in treatment approaches for Indigenous, non-Indigenous and migrant populations. The subject will also examine appropriate approaches to acute and chronic pain management. Students will apply a clinical reasoning process to develop comprehensive pharmaceutical treatment plans to manage psychological, musculoskeletal and respiratory conditions prevalent in northern Australia and tropical regions.

Learning Outcomes

• Describe the pathophysiology and clinical presentation of common neurological, psychiatric, musculoskeletal and respiratory conditions relevant to pharmacy practice
• Demonstrate appropriate screening and clinical skills necessary for the prevention, identification, and management of these conditions
• Develop skills relating to the use of clinical guidelines and their application to the management of patients
• Apply a clinical reasoning process to develop a comprehensive pharmaceutical care plan that includes prescription, over-the-counter complementary and non-pharmacological treatment options
• Demonstrate professional communication withpatients and other health professionals

Subject Assessment

• Written > Test/Quiz 1 - (10%) - Individual
• Oral > Presentation 1 - (20%) - Individual
• Written > Case report 1 - (40%) - Individual
• Performance/Practice/Product > Objective structured clinical examination (OSCE) - (20%) - Individual
• Written > Test/Quiz 2 - (10%) - Individual

Note that minor variations might occur due to the continuous subject quality improvement process, and in case of minor variation(s) in assessment details, the Subject Outline represents the latest official information.

Assumed Knowledge:  As this is a core level 3 subject in the BPharm(Hons)/MPharm pathway, students will be expected to have completed all core level 1 and 2 subjects.

Availabilities